Dashboard
Manage Tickers

MRKR


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

marker-therapeutics-announces-first-patient-treated-in-ots-program-with-encouraging-preliminary-safety-data
Marker Therapeutics Announces First Patien...
10/06/2025 11:33:20

Marker Therapeutics initiated Phase 1 RAPID study to investigate Multi-Antigen Recognizing (MAR) T cells as an Off-the-Shelf (O...

marker-therapeutics-stock-drops-after-report-about-lymphoma-treatment
Marker Therapeutics Stock Drops After Repo...
08/26/2025 16:34:05

Marker Therapeutics reports strong safety and efficacy data for MT-601 in lymphoma patients, with durable responses and no seri...

marker-therapeutics-reports-66-orr-and-50-cr-in-nhl-patients-from-phase-1-apollo-study-of-mt-601-shows-favorable-safety-profile-with-no-dlts-prepares-dose-expansion-in-relapsed-dlbcl
Marker Therapeutics Reports 66% ORR And 50...
08/26/2025 11:03:12

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
07/17/2025 17:06:01

marker-therapeutics-shares-resume-trade
Marker Therapeutics Shares Resume Trade
07/17/2025 14:13:16

dow-jumps-over-100-points-pepsico-posts-upbeat-earnings
Dow Jumps Over 100 Points; PepsiCo Posts U...
07/17/2025 14:12:17

marker-therapeutics-shares-halted-on-circuit-breaker-to-the-upside-stock-now-up-1244
Marker Therapeutics Shares Halted On Circu...
07/17/2025 14:09:49

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
07/17/2025 12:08:10

marker-therapeutics-collaborates-with-cellipont-bioservices-to-accelerate-cgmp-manufacturing-of-mt-601-mar-t-cell-therapy-for-lymphoma
Marker Therapeutics Collaborates With Cell...
06/17/2025 12:08:13

Marker Therapeutics, Inc. (NASDAQ:MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation T cell...

marker-therapeutics-reports-scientific-evidence-from-phase-1-apollo-study-demonstrating-that-lymphodepletion-improves-expansion-and-persistence-of-mar-t-cells
Marker Therapeutics Reports Scientific Evi...
05/20/2025 12:01:50

Preconditioning with lymphodepletion linked to stronger MAR-T cells response and suggests enhanced anti-tumor activityHighest e...

marker-therapeutics-to-highlight-multi-antigen-recognizing-t-cells-in-high-profile-panel-on-car-t-cell-therapies
Marker Therapeutics To Highlight Multi-Ant...
05/19/2025 12:10:09

MARKER THERAPEUTICS, INC. (NASDAQ:MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation T cell...

wbb-securities-reiterates-strong-buy-on-marker-therapeutics-maintains-125-price-target
WBB Securities Reiterates Strong Buy on Ma...
04/01/2025 10:09:45

WBB Securities analyst Steve Brozak reiterates Marker Therapeutics (NASDAQ:MRKR) with a Strong Buy and maintains $12.5 price...

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
03/14/2025 12:10:28

this-krystal-biotech-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-wednesday
This Krystal Biotech Analyst Begins Covera...
03/05/2025 17:24:09

canaccord-genuity-initiates-coverage-on-marker-therapeutics-with-buy-rating-announces-price-target-of-8
Canaccord Genuity Initiates Coverage On Ma...
03/05/2025 10:41:23

Canaccord Genuity analyst John Newman initiates coverage on Marker Therapeutics (NASDAQ:MRKR) with a Buy rating and announce...

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
12/19/2024 21:06:40

marker-therapeutics-reports-results-from-phase-1-apollo-study-of-mt-601-in-relapsed-lymphoma-showing-78-objective-response-rate-and-444-complete-responses-with-well-tolerated-safety-profile-and-no-icans-observed
Marker Therapeutics Reports Results From P...
12/19/2024 13:16:22

marker-therapeutics-secures-161m-in-private-placement-to-advance-phase-1-apollo-study-of-mt-601-t-cell-therapy-for-lymphoma-patients-relapsed-after-anti-cd19-car-t-treatment
Marker Therapeutics Secures $16.1M In Priv...
12/19/2024 13:14:47

marker-therapeutics-wins-95m-grant-to-study-pancreatic-cancer-therapy
Marker Therapeutics Wins $9.5M Grant to St...
12/17/2024 12:07:40

Marker Therapeutics, Inc. (NASDAQ:MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation T cell...

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
12/05/2024 21:05:47

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION